Revolution Medicines (RVMD)
(Real Time Quote from BATS)
$38.96 USD
-0.03 (-0.08%)
Updated May 17, 2024 09:37 AM ET
3-Hold of 5 3
F Value F Growth B Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/13/24 |
---|---|
Current Quarter | -0.75 |
EPS Last Quarter | -0.70 |
Last EPS Surprise | 6.67% |
ABR | 1.08 |
Earnings ESP
|
-0.37% |
---|---|
Current Year | -3.12 |
Next Year | -3.54 |
EPS (TTM) | -3.75 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 5.25M | 5.25M | 15.75M | 21.00M |
# of Estimates | 2 | 2 | 2 | 2 |
High Estimate | 6.00M | 6.00M | 18.00M | 24.00M |
Low Estimate | 4.50M | 4.50M | 13.50M | 18.00M |
Year ago Sales | 3.82M | 0.00M | 11.58M | 15.75M |
Year over Year Growth Est. | 37.43% | NA | 36.01% | 33.33% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.75 | -0.80 | -3.12 | -3.54 |
# of Estimates | 9 | 8 | 10 | 10 |
Most Recent Consensus | -0.73 | -0.77 | -3.00 | -3.46 |
High Estimate | -0.73 | -0.77 | -3.00 | -3.27 |
Low Estimate | -0.77 | -0.84 | -3.62 | -3.84 |
Year ago EPS | -0.92 | -0.99 | -3.86 | -3.12 |
Year over Year Growth Est. | 18.48% | 19.19% | 19.17% | -13.30% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 1 | 0 | 2 | 1 |
Up Last 30 Days | 4 | 2 | 7 | 4 |
Up Last 60 Days | 4 | 2 | 6 | 4 |
Down Last 7 Days | 0 | 1 | 1 | 1 |
Down Last 30 Days | 2 | 3 | 3 | 5 |
Down Last 60 Days | 2 | 3 | 4 | 5 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.75 | -0.80 | -3.12 | -3.54 |
7 Days Ago | -0.75 | -0.80 | -3.14 | -3.52 |
30 Days Ago | -0.76 | -0.81 | -3.18 | -3.40 |
60 Days Ago | -0.76 | -0.81 | -3.17 | -3.39 |
90 Days Ago | -0.83 | -0.85 | -3.20 | -3.15 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.76 | -0.80 | -3.12 | -3.54 |
Zacks Consensus Estimate | -0.75 | -0.80 | -3.12 | -3.54 |
Earnings ESP | -0.37% | -0.52% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.70 | -1.14 | -0.99 | -0.92 | NA |
Estimate | -0.75 | -0.86 | -1.01 | -0.83 | NA |
Difference | 0.05 | -0.28 | 0.02 | -0.09 | -0.08 |
Surprise | 6.67% | -32.56% | 1.98% | -10.84% | -8.69% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more